We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$266M
AUM Growth
-$43.4M
Cap. Flow
-$44.2M
Cap. Flow %
-16.65%
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.06M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$2.27M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.93M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$1.56M
5
AXON
Axon Enterprise
AXON
+$1.1M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$13M
2
MGNX icon
MacroGenics
MGNX
+$6.84M
3
BABA icon
Alibaba
BABA
+$3.42M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$3.21M
5
HCA icon
HCA Healthcare
HCA
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 23.9%
2 Communication Services 19.6%
3 Energy 16.27%
4 Industrials 12.61%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APC
26
DELISTED
Anadarko Petroleum
APC
$4.04M 1.52%
49,035
-2,160
-4% -$188K
XOM icon
27
ExxonMobil
XOM
$644B
$4M 1.51%
43,247
– –
UBA
28
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.72M 1.4%
170,199
-1,855
-1% -$40.3K
APA icon
29
APA Corp
APA
$14.9B
$3.72M 1.4%
59,403
-6,415
-10% -$456K
IBM icon
30
IBM
IBM
$222B
$3.68M 1.38%
23,967
-3,091
-11% -$492K
BAY
31
DELISTED
BAYER AG SPONS ADR
BAY
$3.63M 1.37%
26,539
-180
-0.7% -$24.6K
EOG icon
32
EOG Resources
EOG
$75.2B
$3.59M 1.35%
38,961
-288
-0.7% -$26.8K
PM icon
33
Philip Morris
PM
$299B
$3.5M 1.32%
42,925
-370
-0.9% -$31.8K
MGNX icon
34
MacroGenics
MGNX
$263M
$3.44M 1.29%
98,015
-274,483
-74% -$6.84M
CEO
35
DELISTED
CNOOC Limited
CEO
$3.44M 1.29%
25,377
-795
-3% -$119K
T icon
36
AT&T
T
$178B
$3.43M 1.29%
135,118
-1,165
-0.9% -$30.2K
TYPE
37
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.4M 1.28%
118,115
-1,875
-2% -$52.5K
LMT icon
38
Lockheed Martin
LMT
$130B
$3.36M 1.27%
17,463
-115
-0.7% -$21.3K
NTI
39
DELISTED
NORTHERN TIER ENERGY LP CLASS A
NTI
$3.23M 1.21%
145,675
-1,700
-1% -$40.6K
CVX icon
40
Chevron
CVX
$396B
$2.94M 1.11%
26,170
-135
-0.5% -$15.3K
CMCSA icon
41
Comcast
CMCSA
$96B
$2.91M 1.09%
100,200
– –
APL
42
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
$2.89M 1.09%
106,179
-1,300
-1% -$42K
CVI icon
43
CVR Energy
CVI
$4.2B
$2.88M 1.08%
74,300
– –
SNY icon
44
Sanofi
SNY
$107B
$2.78M 1.05%
60,920
-600
-1% -$29.1K
HCA icon
45
HCA Healthcare
HCA
$90.5B
$2.71M 1.02%
36,965
-41,790
-53% -$2.94M
CELG
46
DELISTED
Celgene Corp
CELG
$2.67M 1.01%
23,887
+8,887
+59% +$937K
ABBV icon
47
AbbVie
ABBV
$451B
$2.67M 1.01%
40,800
– –
PRGO icon
48
Perrigo
PRGO
$2.01B
$2.49M 0.94%
14,912
-26
-0.2% -$4.07K
CPRX
49
DELISTED
Catalyst Pharmaceutical
CPRX
$2.46M 0.92%
+826,500
New +$2.27M
MON
50
DELISTED
Monsanto Co
MON
$2.38M 0.9%
19,925
-210
-1% -$24.4K
1
2
3 4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.

  • Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
  • Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
  • Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
  • Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
  • Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
  • Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
  • Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.

Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.